142 related articles for article (PubMed ID: 19256339)
1. [Characterization and analysis of the aggregation of a single-chain chimeric anti-ErbB2 antibody].
Zhu J; Rong Z; Jiang B; Liu J
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1918-23. PubMed ID: 19256339
[TBL] [Abstract][Full Text] [Related]
2. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)].
Xie ZG; Guo N; Shi M; Feng JN; Yu M; Sun YX; Shen BF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):371-4. PubMed ID: 12673393
[TBL] [Abstract][Full Text] [Related]
3. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
Arndt KM; Müller KM; Plückthun A
J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
[TBL] [Abstract][Full Text] [Related]
5. Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.
Geng SS; Feng J; Li Y; Sun Y; Gu X; Huang Y; Wang Y; Kang X; Chang H; Shen B
Cell Mol Immunol; 2006 Dec; 3(6):439-43. PubMed ID: 17257497
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and identification of anti-carbofuran single chain Fv gene.
Wang H; Yang J; Liu X; Liang Y; Lei H; Shen Y; Xu X; Sun Y; Xu Z; He Y
Biotechnol Prog; 2009; 25(4):1018-24. PubMed ID: 19653307
[TBL] [Abstract][Full Text] [Related]
7. The design, construction and function of a new chimeric anti-CD20 antibody.
Wang Y; Feng J; Huang Y; Gu X; Sun Y; Li Y; Shen B
J Biotechnol; 2007 May; 129(4):726-31. PubMed ID: 17433484
[TBL] [Abstract][Full Text] [Related]
8. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
9. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
Wörn A; Plückthun A
Biochemistry; 1999 Jul; 38(27):8739-50. PubMed ID: 10393549
[TBL] [Abstract][Full Text] [Related]
10. Codon optimization, expression, and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris.
Hu S; Li L; Qiao J; Guo Y; Cheng L; Liu J
Protein Expr Purif; 2006 May; 47(1):249-57. PubMed ID: 16403645
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of anti-clenbuterol single chain Fv recombinant vector].
Wang H; Liang Y; Yang J; Liu X; Zhang H; Lei H; Shen Y; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1470-4. PubMed ID: 18998553
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2.
Liu Y; Zhou H; Zhu J; Gao Y; Niu L; Liu J; Teng M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):692-4. PubMed ID: 19574641
[TBL] [Abstract][Full Text] [Related]
13. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
Weisser NE; Hall JC
Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a novel recombinant single-chain variable fragment antibody against Western equine encephalitis virus.
Long MC; Jager S; Mah DC; Jebailey L; Mah MA; Masri SA; Nagata LP
Hybridoma; 2000 Feb; 19(1):1-13. PubMed ID: 10768836
[TBL] [Abstract][Full Text] [Related]
15. Production of scFv-Fc fusion protein using genetically manipulated quails.
Kawabe Y; Kamihira M; Ono K; Kyogoku K; Nishijima K; Iijima S
J Biosci Bioeng; 2006 Oct; 102(4):297-303. PubMed ID: 17116575
[TBL] [Abstract][Full Text] [Related]
16. Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents.
Villani ME; Di Carli M; Donini M; Traversini G; Lico C; Franconi R; Benvenuto E; Desiderio A
J Immunol Methods; 2008 Jan; 329(1-2):11-20. PubMed ID: 17980894
[TBL] [Abstract][Full Text] [Related]
17. Antibody therapeutics, antibody engineering, and the merits of protein stability.
Demarest SJ; Glaser SM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
[TBL] [Abstract][Full Text] [Related]
18. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
19. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
[TBL] [Abstract][Full Text] [Related]
20. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
